The association between cortisol:C-reactive protein ratio and depressive fatigue is a function of CRP rather than cortisol

Title
The association between cortisol:C-reactive protein ratio and depressive fatigue is a function of CRP rather than cortisol
Publication Date
2019-08-27
Author(s)
Sharpley, Christopher F
( author )
OrcID: https://orcid.org/0000-0001-7922-4848
Email: csharpl3@une.edu.au
UNE Id une-id:csharpl3
Bitsika, Vicki
( author )
OrcID: https://orcid.org/0000-0003-2518-6684
Email: vbitsik2@une.edu.au
UNE Id une-id:vbitsik2
McMillan, Mary E
( author )
OrcID: https://orcid.org/0000-0002-2336-3985
Email: mrookle2@une.edu.au
UNE Id une-id:mrookle2
Jesulola, Emmanuel
Agnew, Linda L
( author )
OrcID: https://orcid.org/0000-0002-2803-0995
Email: lagnew2@une.edu.au
UNE Id une-id:lagnew2
Type of document
Journal Article
Language
en
Entity Type
Publication
Publisher
Dove Medical Press Ltd
Place of publication
United Kingdom
DOI
10.2147/NDT.S213839
UNE publication id
une:1959.11/28092
Abstract
Purpose: Hormonal and inflammatory factors have been suggested as potentially influencing depressive state and depressive symptoms, but rarely compared for their relative contribution to these states and to specific depressive symptoms. This study examined cortisol:C-reactive protein (CRP) ratio, plus cortisol and CRP separately, as correlates of global depression and fatigue-related depression.
Patients and methods: One hundred and twenty-six community volunteers from rural Australia provided saliva and serum samples, and also completed a depression inventory.
Results: There was a significant correlation between cortisol:CRP ratio and depression-related fatigue, and this resolved to the effects of CRP rather than cortisol. Most of the variance in this association came from patients who were "depressed", and there were no significant gender associations.
Conclusion: Inflammation, rather than HPA-axis activity, was associated with depression-related fatigue, supporting a model that places inflammation as a contributor to one of the major symptoms and predictors of depression. Individualization of therapy for depression-related fatigue in chronically stressed or physically ill patients might benefit from future research into cytokine therapy.
Link
Citation
Neuropsychiatric Disease and Treatment, v.15, p. 2467-2475
ISSN
1178-2021
Pubmed ID
31695383
Start page
2467
End page
2475
Rights
Attribution-NonCommercial 3.0 Australia

Files:

NameSizeformatDescriptionLink
openpublished/TheAssociationSharpleyBitsikaMcMillanAgnew2019JournalArticle.pdf 300.546 KB application/pdf Published version View document